We use cookies on our site to track usage and preferences. Learn more

Lonza and CN Bio Announce Distribution Agreement

  • Date 20 Jul 2021

Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimixTM Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical data is generated. With prequalified cells, customers can avoid having to trial numerous cell types in order to be assured of finding ones that will grow and behave functionally in 3D culture and fast-track their route to generating reliable and robust data.

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more